The Board of Directors of BrightGene Bio-Medical Technology Co., Ltd. has authorized a buyback plan on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35.67 CNY | -1.27% |
|
+4.12% | +1.91% |
May. 07 | China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% | MT |
May. 07 | BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.91% | 2.07B | |
+54.07% | 809B | |
+39.95% | 624B | |
-7.05% | 351B | |
+5.72% | 289B | |
+14.00% | 240B | |
+14.56% | 220B | |
+0.20% | 219B | |
+7.42% | 166B | |
-3.79% | 157B |
- Stock Market
- Equities
- 688166 Stock
- News BrightGene Bio-Medical Technology Co., Ltd.
- BrightGene Bio-Medical Technology Co., Ltd. authorizes a Buyback Plan.